Corporate news announcement processed and transmitted by Hugin AS.
The issuer is solely responsible for the content of this
announcement.
----------------------------------------------------------------------
--------------
* Many Years of Experience as CFO
* Joining Symrise as of December 1, 2009
The Supervisory Board of Symrise AG has appointed Bernd Hirsch as the
new CFO of the Company. Mr. Hirsch will be joining Symrise from
exchange-listed Carl Zeiss Meditec AG, Jena, where he has been active
as CFO since 2002.
Bernd Hirsch (39) will be assuming the position of Symrise AG CFO
from his predecessor, Dominique Yates, as of December 1, 2009. As was
already announced on November 5, Mr. Yates is leaving the Company at
the end of year at his own request and on best terms. The careful and
thorough transfer of responsibility for Company finances is, thus,
ensured.
At Carl Zeiss Meditec AG, Mr. Hirsch has considerably contributed to
the development of the company to global market leader in
ophthalmology and microsurgery systems since his appointment as CFO
in 2002. There, his responsibilities included the areas of finance &
controlling, investor relations, legal, and tax affairs. In addition,
he spearheaded supply chain optimization and was in charge of the
area of Business Process Excellence, including IT.
Before his time at Carl Zeiss Meditec AG, Mr. Hirsch was involved in
many international projects as the Head of Mergers and Acquisitions
at Carl Zeiss AG and as Head of Auditing at the auditing company
Arthur Andersen. He earned a degree in business from the University
of Würzburg.
Andreas Schmid, Chairman of the Supervisory Board of Symrise AG,
comments: "We are pleased that we have been able to name Bernd Hirsch
as CFO. Mr. Hirsch has already gained many years of experience as the
CFO of a dynamic, exchange-listed company, despite his young age. He
is equally familiar with the challenges of a rapidly expanding,
globally active Group such as Symrise and the requirements of the
international capital markets."
About Symrise
Symrise is a global supplier of fragrances, flavorings and raw
materials as well as active ingredients for the perfume, cosmetics
and food industry.
Its sales of ¤ 1.32 billion in 2008 place the Company among the top
four in the international flavor and fragrance market. Headquartered
in Holzminden, Germany, Symrise is represented in more than 35
countries in Europe, Asia, the United States and South America.
Used by manufacturers of perfumes, cosmetics and foods, our
innovative products are an inseparable part of daily life. At Symrise
we combine an awareness of consumer trends with cutting-edge
technologies, focusing on developing innovative fashion and lifestyle
products that have additional practical value for the consumer.
Symrise - always inspiring more...
www.symrise.com
For press queries, contact: For investor queries, contact:
Bernhard Kott Dr. Andrea Rolvering
Tel. +49 (0)5531 90-1721 Tel. +49 (0)69 75 93 75 94
bernhard.kott@symrise.com andrea.rolvering@symrise.com
--- End of Message ---
Symrise AG
Mühlenfeldstraße 1 Holzminden Germany
WKN: SYM999; ISIN:
DE000SYM9999; Index: MDAX, TecDAX;
Listed: Regulierter Markt in Frankfurter Wertpapierbörse, Freiverkehr
in Bayerische Börse München,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr
in Börse Berlin,
Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart,
Prime Standard in Frankfurter Wertpapierbörse;
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.